Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Lin BioScience, Inc. (6696) Financial Statements

Lin BioScience, Inc. Financial Overview

Lin BioScience, Inc.'s market cap is currently NT$136.11B. The company's EPS TTM is NT$-13.93; its P/E ratio is -11.99; Lin BioScience, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 0.00NT$ 0.00NT$ 0.00NT$ 0.00NT$ 0.00
Gross ProfitNT$ -23.79MNT$ -20.21MNT$ -17.93MNT$ -11.16MNT$ -4.39M
Operating IncomeNT$ -2.86BNT$ -1.46BNT$ -1.10BNT$ -445.13MNT$ -338.28M
EBITDANT$ -2.61BNT$ -1.44BNT$ -1.07BNT$ -465.84MNT$ -485.95M
Net IncomeNT$ -1.36BNT$ -744.27MNT$ -687.19MNT$ -313.52MNT$ -434.70M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 16.29BNT$ 5.21BNT$ 3.26BNT$ 1.65BNT$ 806.85M
Total AssetsNT$ 25.43BNT$ 5.53BNT$ 3.60BNT$ 1.85BNT$ 923.23M
Total DebtNT$ 22.81MNT$ 33.99MNT$ 42.87MNT$ 46.50MNT$ 2.24M
Net DebtNT$ -11.89BNT$ -1.45BNT$ -3.22BNT$ -1.60BNT$ -804.61M
Total LiabilitiesNT$ 291.24MNT$ 173.22MNT$ 167.73MNT$ 116.06MNT$ 470.25M
Stockholders' EquityNT$ 10.73BNT$ 2.85BNT$ 2.14BNT$ 1.23BNT$ 541.57M
Cash Flow
Free Cash FlowNT$ -1.45BNT$ -1.03BNT$ -1.01BNT$ -383.40MNT$ -291.96M
Operating Cash FlowNT$ -1.44BNT$ -1.02BNT$ -1.01BNT$ -361.01MNT$ -289.83M
Investing Cash FlowNT$ -9.36BNT$ -3.55BNT$ 1.87MNT$ -24.05MNT$ -1.48M
Financing Cash FlowNT$ 20.48BNT$ 2.66BNT$ 2.64BNT$ 1.13BNT$ 28.32M

Currency in TWD

Lin BioScience, Inc. Earnings and Revenue History

-1.5B-1B-500M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Lin BioScience, Inc. Liabilities to Assets

010B20B30B0 %20 %40 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Lin BioScience, Inc. Cash Flow

-20B-10B010B20B30B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Lin BioScience, Inc. Forecast EPS vs Actual EPS

Earnings >